Sanofi SA - Total Other Finance Cost
Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Millions.
The item "Total-Other-Finance-Cost" stands at -252.00 Million Euros for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 09/30/2020.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -444.00 Million Euros compared to the value the year prior.
The 1 year change is -444.00 Million Euros.
The 3 year change is -96.00 Million Euros.
The 10 year change is 296.00 Million Euros.
The Serie's change in Euros from it's minimum value, on 06/30/2017, to it's latest available value, on 09/30/2025, is +471.00 Million.
The Serie's change in Euros from it's maximum value, on 06/30/2024, to it's latest available value, on 09/30/2025, is -444.00 Million.
Total Other Finance Cost for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Total Other Finance Cost | 905,699,262,464.00 |
 | Johnson & Johnson - Total Other Finance Cost | 486,508,953,600.00 |
 | AbbVie Inc - Total Other Finance Cost | 399,570,305,024.00 |
 | Roche Holding AG - Total Other Finance Cost | 317,433,206,677.55 |
 | AstraZeneca PLC - Total Other Finance Cost | 280,205,508,085.11 |